(Q34120601)

31 July 2017

0 references

Is vascular mortality increased in hypopituitarism? (English)

1 reference

31 July 2017

Erfurth EM

1

1 reference

31 July 2017

Bülow B

series ordinal

2

1 reference

31 July 2017

Hagmar LE

series ordinal

3

1 reference

31 July 2017

1 October 2000

1 reference

31 July 2017

1 reference

31 July 2017

3

1 reference

31 July 2017

2

1 reference

31 July 2017

77-81

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1009901707125

31 July 2017

0 references

cites work

Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults

1 reference

12 December 2020

Endocrine function in patients with pituitary adenoma before and after hypophysectomy

1 reference

12 December 2020

Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas

1 reference

12 December 2020

Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults

1 reference

12 December 2020

Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects

1 reference

12 December 2020

Hypopituitarism following external radiotherapy for pituitary tumours in adults.

1 reference

12 December 2020

The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe

1 reference

12 December 2020

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

12 December 2020

The effect of radiation on carotid arteries. A review article

1 reference

12 December 2020

Emerging epidemic of cardiovascular disease in developing countries

1 reference

12 December 2020

Life expectancy following surgery for pituitary tumours

1 reference

12 December 2020

Cardiovascular risk factors in adult patients with growth hormone deficiency

1 reference

12 December 2020

Increased cerebrovascular mortality in patients with hypopituitarism

1 reference

12 December 2020

Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency

1 reference

12 December 2020

Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.

1 reference

12 December 2020

The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients

1 reference

12 December 2020

The effect of hypopituitarism on life expectancy

1 reference

12 December 2020

Treatment of adults with growth hormone (GH) deficiency with recombinant human GH

1 reference

12 December 2020

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

12 December 2020

Regionalizing mortality data: ischaemic heart disease in Norway

1 reference

12 December 2020

Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

1 reference

12 December 2020

Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1009901707125

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference